Roundtable Discussion; The Future of Mineral Sands. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Monday broker round-up

Mon, 08th Mar 2021 13:00

(Sharecast News) - Entain: Numis upgrades to add with a target price of 1,675p.

Aggreko: Berenberg reiterates hold with a target price of 880p.

Meggitt: Berenberg reiterates buy with a target price of 480p.

Spirent Communications: Canaccord reiterates buy with a target price of 275p.

AstraZeneca: Deutsche Bank reiterates buy with a target price of 10,000p.

Essentra: Deutsche Bank reiterates buy with a target price of 360p.

Galliford Try: Liberum reiterates buy with a target price of 200p.

Clarkson: Liberum reiterates buy with a target price of 3,200p.

Pearson: Numis reiterates sell with a target price of 480p.

Related Shares

More News

3 May 2024 12:17

CORRECT: Angle shares up on assay development deal with AstraZeneca

(Correcting company name in headline)

3 May 2024 11:50

Angle shares up on assay development deal with AstraZenaca

(Alliance News) - Shares in Angle PLC jumped on Friday, after the company said it has been chosen to develop a prostate cancer assay using its Parsort...

3 May 2024 07:50

LONDON BRIEFING: InterContinental Hotels makes first-quarter progress

(Alliance News) - London's FTSE 100 is called to open higher on Friday, on the expectation of a softer US jobs report, which could take some sting out...

2 May 2024 10:04

AstraZeneca notes positive trial results for Calquence treatment

(Alliance News) - AstraZeneca PLC on Thursday said it observed positive high-level results in the Echo phase 3 trial of its Calquence treatment for pr...

2 May 2024 07:45

AstraZeneca reports positive results from blood cancer drug trial

(Sharecast News) - AstraZeneca has reported positive results from the use of its Calquence drug in a clinical trial to treat a rare type of blood canc...